SEARCH

SEARCH BY CITATION

References

  • Asanuma K., Ma Y., Okulski J., Dhawan V., Chaly T., Carbon M., Bressman S. B. and Eidelberg D. (2005) Decreased striatal D2 receptor binding in non-manifesting carriers of the DYT1 dystonia mutation. Neurology 64, 347349.
  • Augood S. J., Martin D. M., Ozelius L. J., Breakefield X. O., Penney J. B. Jr and Standaert D. G. (1999) Distribution of the mRNA encoding torsinA abd torsinB in the normal adult human brain. Ann. Neurol. 46, 761769.
  • Augood S. J., Hollingsworth Z., Albers D. S., Yang L., Leung J., Breakefield X. O. and Standaert D. G. (2004) Dopamine transmission in DYT1 dystonia. Adv. Neurol. 94, 5360.
  • Balcioglu A., Zhang K. and Tarazi F. I. (2003) Dopamine depletion abolishes apomorphine and amphetamine-induced increases in extracellular serotonin levels in the striatum of conscious rats. A microdialysis study. Neuroscience 119, 10451053.
  • Bressman S. B., Raymond D., Wendt K., Saunders-Pullman R., De leon D., Fahn S., Ozelius L. and Risch N. (2002) Diagnostic criteria for dystonia in DYT1 families. Neurology 59, 17801782.
  • Cao S., Gelwix C. C., Caldwell K. A. and Caldwell G. A. (2005) Torsin-mediated protection from cellular stress in the dopaminergic neurons of Caenorhabditis elegans. J. Neurosci. 25, 38013812.
  • Carboni E., Spielewoy C., Vacca C., Nosten-Bertrand M., Giros B. and Di Chiara G. (2001) Cocaine and amphetamine increase extracellular dopamine in the nucleus accumbens of mice lacking the dopamine transporter gene. J. Neurosci. 21, 14.
  • Cha J. J., Kosinski C. M., Kerner J. A., Alsdorf S. A., Mangiarini L., Davies S. W., Penney J. B., Bates G. P. and Young A. B. (1998) Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene. Proc. Natl Acad. Sci. USA 95, 64806485.
  • Dang M. T., Yokoi F., McNaught K. P., Jengelley T. A., Jackson T., Li J. and Li Y. (2005) Generation and characterization of Dyt1 λGAG knock-in mouse as a model for early-onset dystonia. Exp. Neurol. 196, 452463.
  • Dang M. T., Yokoi F., Pence M. A. and Li Y. (2006) Motor deficits and hyperactivity in Dyt1 knockdown mice. Neurosci. Res. 56, 470474.
  • Franklin K. B. and Paxinos G. (1997) The Mouse Brain in Stereotaxic Coordinates. Academic press, Burlington, MA, USA.
  • Furukawa Y., Hornykiewicz O., Fahn S. and Kish S. J. (2000) Striatal dopamine in early-onset primary torsin dystonia with the DYT1 mutation. Neurology 54, 11931195.
  • Ghilardi M. R., Carbon M., Silvestri G., Dhawan V., Tagliati M., Bressman S., Ghez C. and Eidelberg D. (2003) Impaired sequence learning in carriers of the DYT1 dystonia mutation. Ann. Neurol. 54, 102109.
  • Ichinose H, Ohye T., Takahashi E. et al. (1994) Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene. Nature. Genet. 8, 236242.
  • Jankovic J. and Fahn S. (1993) Dystonic disorders, in Parkinson’s Disease and Movement Disorders (JankovicJ. and TolosaE., eds), pp. 337374. Williams and Wilkins, Baltimore.
  • Klien C., Ozelius L. J. and Breakefield X. O. (2007) Genetic evaluation in primary dystonia, in Handbook of Dystonia (StacyM. ed.), pp. 21–44. Informa Healthcare, New York.
  • Knappskog P. M., Flatmark T., Mallet J., Ludecke B. and Bartholome K. (1995) Recessively inherited L-DOPA-responsive dystonia caused by a point mutation (Q381 K) in the tyrosine hydroxylase gene. Hum. Mol. Genet. 4, 12091212.
  • Kuczenski R., Segal D. S. and Todd P. K. (1997) Behavioral sensitization and extracellular dopamine responses to amphetamine after various treatments. Psychopharmacology 134, 221229.
  • Leung J. C., Klein C., Friedman J. et al. (2001) Novel mutation in the TOR1A (DYT1) gene in atypical early onset dystonia and polymorphisms in dystonia and early onset parkinsonism. Neurogenetics 3, 133143.
  • Lupas A., Flagan J. M., Tamura T. and Baumeister W. (1997) Self-compartmentalization proteases. Trends Biochem. Sci. 22, 399404.
  • McNaught K. S., Kapustin A., Jackson T., Jengelley T. A., Jnobaptiste R., Shashidharan P., Perl D. P., Pasik P. and Olanow C. W. (2004) Brainstem pathology in DYT1 primary torsion dystonia. Ann. Neurol. 56, 540547.
  • Misbahuddin A., Placzek M. R., Taanman J. W., Gschmeissner S., Schiavo G., Cooper J. M. and Warner T. T. (2005) Mutant torsinA, which causes early-onset primary torsion dystonia, is redistributed to membranous structures enriched in vesicular monoamine transporter in cultured human SH-SY5Y cells. Mov. Dis. 20, 432440.
  • Mizoguchi K., Yuzurihara M., Nagata M., Ishige A., Sasaki H. and Tabira T. (2002) Dopamine-receptor stimulation in the prefrontal cortex ameliorates stress-induced rotarod impairment. Pharmacol. Biochem. Behav. 72, 723728.
  • Neuwald A. F., Aravind L., Spouge J. L. and Koonin E. V. (1999) AAA+: a class of chaperone-like ATPases associated with the assembly, operation, and disassembly of protein complexes. Genome Res. 9, 2743.
  • Ogura T. and Wilkinson A. J. (2001) AAA+ superfamily ATPases: common structure–diverse function. Genes Cells 6, 575597.
  • Ogura T., Ogata M., Akita H., Jitsuki S., Akiba L., Noda K., Hoka S. and Saji M. (2005) Impaired acquisition of skilled behavior in rotarod task by moderate depletion of striatal dopamine in a pre-symptomatic stage model of Parkinson’s disease. Neurosci. Res. 51, 299308.
  • Ozelius L. J., Hewett J., Page C. et al. (1997) The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein. Nat. Genet. 17, 4048.
  • Rostasy K., Augood S. J., Hewett J. W., Leung J. C., Sasaki H., Ozelius L. J., Ramesh V., Standaert D. G., Breakefield X. O. and Hedreen J. C. (2003) TorsinA protein and neuropathology in early onset generalized dystonia with GAG deletion. Neurobiol. Dis. 12, 1124.
  • Rouge-Pont F., Usiello A., Benoit-Marand M., Gonon F., Piazza P. V. and Borrelli E. (2002) Changes in extracellular dopamine-induced by morphine and cocaine: crucial control by D2 receptors. J. Neurosci. 22, 32933301.
  • Rupniak N. M., Jenner P. and Marsden C. D. (1986) Acute dystonia induced by neuroleptic drugs. Psychopharmacology 88, 403419.
  • Sharma N., Baxter M. G., Petravicz J., Bragg C. D., Schienda A., Standaert D. G. and Breakefield X. O. (2005) Impaired motor learning in mice expressing torsinA with the DYT1 dystonia mutation. J. Neurosci. 25, 53515355.
  • Shashidharan P., Sandu D., Potla U., Armata I. A., Walker R. H., McNaught K. S., Weisz D., Sreenath T., Brin M. F. and Olanow C. W. (2005) Transgenic mouse model of early-onset DYT1 dystonia. Hum. Mol. Genetics 14, 125133.
  • Skidmore F. and Reich S. G. (2005) Tardive dystonia. Curr. Treat. Options Neurol. 7, 231236.
  • Sulzer D., Sonders M. S., Poulsen N. W. and Galli A. (2005) Mechanisms of neurotransmitter release by amphetamines: a review. Prog. Neurobiol. 75, 406433.
  • Torres G. E., Sweeney A. L., Beaulieu J. M., Shashidharan P. and Caron M. G. (2004) Effect of torsinA on membrane proteins reveals a loss of function and a dominant-negative phenotype of the dystonia-associated ΔE-torsinA mutant. Proc. Natl Acad. Sci. USA 101, 1565015655.
  • Vacher C. M., Gassmann M., Desrayaud S., Challet E., Bradaia A., Hoyer D., Waldmeier P., Kaupmann K., Pevet P. and Bettler B. (2006) Hyperdopaminergia and altered locomotor activity in GABAB1-deficient mice. J. Neurochem. 97, 979991.
  • Westerink B. H. C. (1995) Brain microdialysis and its application for the study of animal behaviour. Behav. Brain Res. 70, 103124.